These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30762085)

  • 21. Degloving the Feet: A Severe Case of Hand-Foot Syndrome After Induction Chemotherapy.
    Kasht R; Mukherjee S; Ibrahimi S
    J Cutan Med Surg; 2018; 22(6):609. PubMed ID: 30322303
    [No Abstract]   [Full Text] [Related]  

  • 22. Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study.
    Reagan JL; Sullivan MR; Winer ES; Lansigan F; Cardin MS; Castillo JJ
    Leuk Res; 2015 Aug; 39(8):812-7. PubMed ID: 26045177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ACUTE MYELOID LEUKEMIA COMPLICATED BY DISSEMINATED TUBERCULOSIS AT DIAGNOSIS].
    Maekawa K; Tanaka Y; Shinzato I; Tada K; Takafuta T
    Kekkaku; 2015 Apr; 90(4):469-74. PubMed ID: 26489150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7 + 3 idarubicin is still an effective induction therapy in acute myeloid leukaemia.
    Ramanathan S; Brereton M; Rezo M; Badoux X
    Intern Med J; 2014 Aug; 44(8):823-4. PubMed ID: 25081053
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute myeloid leukaemia with maturation demonstrates persistent disease with prominent megakaryoblastic differentiation 16 days following induction chemotherapy: an intra-myeloid lineage switch mediated by chemotherapy-induced clonal selection.
    Zhao Y; Maule J; McCracken J; Li Y; Rapisardo S; Yang LH; Wang E
    Br J Haematol; 2020 May; 189(3):e64-e67. PubMed ID: 32108332
    [No Abstract]   [Full Text] [Related]  

  • 26. Are adjuncts to induction chemotherapy worthwhile in the treatment of acute myeloid leukemia?
    Ravandi F
    Best Pract Res Clin Haematol; 2014; 27(3-4):241-6. PubMed ID: 25455273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human herpesvirus-6 encephalitis following chemotherapy induction for acute myelogenous leukemia.
    Frey JW; Cherabie JN; Assi MA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28746781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia.
    Girmenia C; Micozzi A; Piciocchi A; Gentile G; Di Caprio L; Nasso D; Minotti C; Capria S; Cartoni C; Alimena G; Meloni G; Amadori S; Foà R; Venditti A
    Leuk Res; 2014 Apr; 38(4):469-74. PubMed ID: 24534569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
    Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
    J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin.
    Dotson J; Elhamdani A; Petryna E; Jamil MO; Alsharedi M
    Int J Hematol; 2019 Mar; 109(3):351-355. PubMed ID: 30506467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in obese patients undergoing induction therapy for acute leukemia.
    Dombrowski L; Mohassel L
    J Oncol Pharm Pract; 2019 Jul; 25(5):1058-1065. PubMed ID: 29726788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Risk-adapted therapy in acute myeloid leukemia].
    Fiegl M; Hiddemann W
    Internist (Berl); 2012 Apr; 53(4):392, 394-9. PubMed ID: 22410942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of FLAG as initial induction chemotherapy followed by autologous hematopoietic stem cell transplantation after IBu conditioning regimen in acute myeloid leukemia with FLT3 mutations].
    Wang B; Yang B; Dong W; Liu D; Ling Y; Cao X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):653-5. PubMed ID: 25052613
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and microbiological profile of infections during induction phase of acute myeloid leukemia.
    Parikh S; Goswami P; Anand A; Panchal H; Patel A; Kulkarni R; Shastri B
    Gulf J Oncolog; 2018 May; 1(27):18-23. PubMed ID: 30145547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Longu F; Fozza C; Dessì L; Longinotti M; Bonfigli S; Careddu MG; Coppola L; Giannico DB; Nieddu RM; Podda L; Pardini S; Dore F; Dore S; Sotgiu G
    Acta Haematol; 2017; 137(1):15-16. PubMed ID: 27806360
    [No Abstract]   [Full Text] [Related]  

  • 37. Fever of unknown origin (FUO) caused by miliary tuberculosis: diagnostic significance of morning temperature spikes.
    Cunha BA; Krakakis J; McDermott BP
    Heart Lung; 2009; 38(1):77-82. PubMed ID: 19150533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytosine arabinoside and daunorubicin induction therapy in a patient with acute myeloid leukemia on chronic hemodialysis.
    Krashin E; Dolberg OJ; Hellmann I; Huitema AD; Rosing H; Ellis M
    Anticancer Drugs; 2016 Sep; 27(8):800-3. PubMed ID: 27254285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Author reply: To PMID 22757980.
    Wei A; Fleming S
    Intern Med J; 2014 Aug; 44(8):825. PubMed ID: 25081054
    [No Abstract]   [Full Text] [Related]  

  • 40. Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.
    Müller-Tidow C; Tschanter P; Röllig C; Thiede C; Koschmieder A; Stelljes M; Koschmieder S; Dugas M; Gerss J; Butterfaß-Bahloul T; Wagner R; Eveslage M; Thiem U; Krause SW; Kaiser U; Kunzmann V; Steffen B; Noppeney R; Herr W; Baldus CD; Schmitz N; Götze K; Reichle A; Kaufmann M; Neubauer A; Schäfer-Eckart K; Hänel M; Peceny R; Frickhofen N; Kiehl M; Giagounidis A; Görner M; Repp R; Link H; Kiani A; Naumann R; Brümmendorf TH; Serve H; Ehninger G; Berdel WE; Krug U;
    Leukemia; 2016 Mar; 30(3):555-61. PubMed ID: 26522083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.